Biotech Takeover Targets Wall Street Eyes After Apogee Deal
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
We compare value-focused dividend growth ETFs to help you spot the best option based on cost, yield, and growth potential.
27,266 articlesAbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
AI is changing how films are made and how money is earned in entertainment. This article translates that shift into c...
A federal judge paused the $81 billion Paramount-Warner merger for two weeks as 12 states challenge the deal over com...
UWM introduces a temporary pricing incentive for eligible refinances and purchases, while Chase launches a short-term...
A lingering story can ride beside your finances like a 'ghost passenger seat: reality.' This article explores how nar...
A cross-chain breach targeting the Verus-Ethereum bridge drained more than $11 million, triggering renewed focus on s...
Retirees face a surprising two-year lag between last-year earnings and Medicare premium changes, even when Social Sec...
A major rumor suggests Adele reportedly returns London to write and record while she contemplates a long pause from m...
A high profile event can reveal how big budgets behave. This article translates that spectacle into actionable person...
Vitalik Buterin reveals an ambitious plan to build 'sanctuary technologies' within Ethereum, aiming to shield people ...
Franklin Templeton is teaming with Ondo to bring tokenized ETFs and other assets to blockchain users. The move sparks...
SUI has introduced gasless stablecoin transfers, eliminating on-chain fees for supported assets and expanding enterpr...